A shot that shrinks belly fat without touching other fat

Original Title

Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This medicine helps people with HIV who have a big belly from treatment get rid of the dangerous fat inside their tummy — but not the soft fat under the skin.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Tesamorelin reduces visceral fat without reducing subcutaneous fat—even though both are in the abdomen.

Common belief: fat loss is global. This study proves fat loss can be anatomically precise—targeting only the dangerous internal fat while sparing the pinchable kind.

Practical Takeaways

If you’re an HIV patient with abdominal fat buildup, ask your doctor about tesamorelin—it’s FDA-approved and can improve both health and self-image.

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.